FindTrial
Sign In

Auxiliary use of remifentanil improves parturients' comfort undergoing secondary Cesarean section under epidural anesthesia

Auxiliary use of remifentanil improves parturients' comfort undergoing secondary Cesarean section under epidural anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018423
Enrollment
Unknown
Registered
2018-09-17
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean section

Interventions

Group R:auxiliary use of remifentanil
Group E:Epidural anesthesia

Sponsors

Huzhou Maternity & Child Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Maternal re-cesarean section confirmed by clinical examination and laboratory examination; single full-term pregnancy, no fetal hypoxia, no other high-risk pregnancy factors; no heart, liver, kidney and other important organ serious diseases.

Exclusion criteria

Exclusion criteria: BMI greater than 29 kg/m2 before pregnancy or weight greater than 91 kg during pregnancy or weight gain more than 20% after pregnancy; skin allergy, infection and contraindication of spinal anesthesia; history of local anesthesia, history of opioid allergy or abuse

Design outcomes

Primary

MeasureTime frame
comfort;—

Secondary

MeasureTime frame
Apgar score;VAS score;—

Countries

China

Contacts

Public ContactYan Wei

Huzhou Maternity & Child Care Hospital

99556890@qq.com+86 13967276541

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026